It was an excellent quarter for the world’s largest biotechnology company, Amgen, Inc. (NASDAQ:AMGN), as it posted a better than expected fourth quarter 2014 and fiscal 2014 financial results. Enbrel® was the primary reason for the growth in sales and revenues of the biotech company along with additional tax credit. The biotechnology company announced its…
Amgen Inc (AMGN) vs. Sanofi SA (SNY)-Regeneron Pharmaceuticals Inc (REGN) Race to Win Hearts
With incidence of cardio-vascular disease growing amongst people on a worldwide scale, it is but natural for pharmaceutical companies to capitalize on the situation by releasing drugs that would combat the disease. To this effect, there are two companies running in the forefront of this race, namely Amgen Inc (NASDAQ:AMGN) which was the first to…